XML 37 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue Recognition (Tables)
9 Months Ended
Sep. 30, 2021
Revenue Recognition [Abstract]  
Disaggregation of Revenue
The following tables present the Company’s revenue disaggregated by geographical region for the three and nine months ended September 30, 2021 and 2020, respectively. Domestic refers to revenue from customers based in the United States, and substantially all foreign revenue is derived from sales to our distributors, primarily in Asia.
 
   
Three Months Ended
September 30, 2021
 
   
Dermatology Recurring Procedures
   
Dermatology Procedures Equipment
   
 
 
TOTAL
 
Domestic
 
$
5,370
   
$
519
   
$
5,889
 
Foreign
   
340
     
1,482
     
1,822
 
Total
 
$
5,710
   
$
2,001
   
$
7,711
 

   
Nine Months Ended
September 30, 2021
 
   
Dermatology Recurring Procedures
   
Dermatology Procedures Equipment
   
 
 
TOTAL
 
Domestic
 
$
14,923
   
$
1,113
   
$
16,036
 
Foreign
   
918
     
3,966
     
4,884
 
Total
 
$
15,841
   
$
5,079
   
$
20,920
 

       
   
Three Months Ended
September 30, 2020
 
   
Dermatology Recurring Procedures
   
Dermatology Procedures Equipment
   
TOTAL
 
Domestic
 
$
3,690
   
$
261
   
$
3,951
 
Foreign
   
145
     
1,517
     
1,662
 
Total
 
$
3,835
   
$
1,778
   
$
5,613
 

   
Nine Months Ended
September 30, 2020
 
   
Dermatology Recurring Procedures
   
Dermatology Procedures Equipment
   
 
 
TOTAL
 
Domestic
 
$
11,957
   
$
701
   
$
12,658
 
Foreign
   
375
     
3,340
     
3,715
 
Total
 
$
12,332
   
$
4,041
   
$
16,373
 
Future Undiscounted Fixed Treatment Code Payments from International Recurring Revenue Customers
The following table summarizes the Company’s expected future undiscounted fixed treatment code payments from international recurring revenue customers as of September 30, 2021:

Remaining 2021
 
$
390
 
2022
   
1,556
 
2023
   
1,479
 
2024
   
1,076
 
2025
   
362
 
Thereafter
   
-
 
Total
 
$
4,863